No Detail Found!

Cytogenetic effects of heptaplatin on SWR/J mouse bone marrow cells.

Author(s)
Khalid M. Al-Anazi Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Kingdom of Saudi Arabia
Abstract
In the present study, the cytogenetic effects of the platinum based anti-tumour drug heptaplatin were analysed by measuring chromosomal aberrations and the mitotic index, in bone marrow cells of SWR/J mice. A single 5, 10 or 12.5 mg/kg body weight (b.wt) intraperitoneal dose of heptaplatin was administered to the experimental animal groups while the control group were injected i.p. with normal saline (0.4 ml). Animals from all the groups were sacrificed at sampling times of 24, 48, and 72 h and their bone marrow cells were scrutinized for cytogenetic damage. It was observed that with the three disparate doses of heptaplatin significantly high levels of chromosomal aberration were seen in animals in the initial 24 h, compared to the normal group but these gradually reduced after 48 and 72 h. A similar trend was observed in aberrations with G, without G and in the mitotic index for all three dosages levels. The present study demonstrates that a single i.p. administration of 5, 10 or 12.5 mg/kg b.wt. of heptaplatin significantly reduces the mitotic indices and highly significantly induces chromosomal aberrations (both numerically and structurally) in proliferative bone marrow cells of SWR/J mice.
Publication Details
Page(s) 1083-1088
DOI DOI not available
Published Journal: Pakistan Journal of Zoology, Volume: 47, Issue: 4, Year: 2015

Request the full text from PASTIC

0

Citations

0

Downloads

167

Views